Microchip Technology Incorporated (MCHP)
NASDAQ: MCHP · Real-Time Price · USD
89.44
-1.20 (-1.32%)
At close: Apr 24, 2026, 4:00 PM EDT
89.38
-0.06 (-0.07%)
After-hours: Apr 24, 2026, 7:53 PM EDT

Microchip Technology Earnings Call Transcripts

Fiscal Year 2026

Fiscal Year 2025

  • Strong growth is expected in data center, communications, and A&D, driven by new product launches and robust design activity. Inventory correction is nearly complete, with bookings and channel restocking set to support revenue growth into 2026. Gross margin and cash flow are improving, with a focus on reducing leverage.

  • Raised guidance for the December quarter follows record bookings and broad-based recovery across end markets. Data center innovation, including the launch of a 3nm PCIe Gen 6 switch, positions the company for growth, while inventory and margin improvements are underway.

  • Bookings and backlog remain strong, supporting above-seasonal expectations for the March quarter. Margin improvement is driven by declining underutilization and inventory charges, with a 60% gross margin targeted soon. Growth is led by data center, aerospace/defense, and FPGA, while capital allocation focuses on deleveraging and maintaining the dividend.

  • Bookings surged in July, with strong growth in AI, data center, and connectivity markets. Inventory is being aggressively reduced, and strategic focus is on AI-driven productivity, new product innovation, and expanding onshore manufacturing. Aerospace, defense, and automotive connectivity are key growth areas.

  • A comprehensive nine-point plan has driven operational efficiency, inventory reduction, and margin expansion, with strong growth in aerospace, industrial, and data center markets. Bookings and sales are rising, inventory correction continues, and above-seasonal growth is expected in upcoming quarters.

  • AGM 2025

    The meeting covered board elections, auditor ratification, and a failed advisory vote on executive compensation, with shareholders expressing concerns over time-based RSU grants. Management reaffirmed its commitment to dividends and outlined improved financial stability for the coming quarters.

  • Bookings and revenue are rebounding, with July bookings at a three-year high and strong aerospace/defense demand. Inventory normalization and margin improvement are underway, while new AI and China strategies are being implemented. Customer relationships and manufacturing flexibility have improved.

  • Bookings and book-to-bill ratios have rebounded, with inventory levels normalizing and broad-based demand recovery. Product diversification in FPGAs, PCIe, and Ethernet is driving margin expansion, while AI and connectivity are key strategic focuses. Customer relationships and operational control have notably improved.

  • Raised guidance follows strong bookings and broad-based recovery driven by inventory replenishment. Margin improvement is expected as inventory write-offs decline and factory output rises. Dividend remains secure, while buybacks are deferred until leverage targets are met.

  • Management is executing a nine-point plan with manufacturing consolidation, improved customer relationships, and a focus on high-growth sectors like connectivity and aerospace. Inventory and margin improvements are expected this year, with bookings and backlog trending upward.

  • A cyclical recovery is underway, with sequential revenue growth, inventory reduction, and improving order trends across both distribution and direct channels. Aggressive pricing on new designs, a sharpened channel strategy, and focus on megatrends and aerospace/defense are expected to drive future growth and margin expansion.

  • Net sales and margins declined year-over-year due to inventory correction, but bookings and backlog are rising, signaling a bottom and expected recovery. Aerospace/defense and AI segments are growing, and the company is returning nearly all free cash flow to shareholders.

  • Significant restructuring is underway, including fab closure and workforce reduction, to align with new margin targets. Inventory and channel management are improving, with bookings and backlog rebounding. Strategic moves in China and Total System Solutions are set to drive future growth and defend market share.

  • Inventory correction is nearly complete, with bookings and backlog improving. Manufacturing capacity has been reduced and inventory management tightened. Growth is focused on new anchor products and megatrends, while financial targets aim for higher margins and sustained R&D investment.

  • Status Update

    Net sales are on track, with inventory correction and bookings improvement signaling recovery. Operational streamlining, accelerated Fab 2 closure, and new product initiatives support long-term growth, while megatrend focus and cost reductions aim to boost margins and profitability.

  • Net sales fell sharply year-over-year amid broad-based weakness and ongoing inventory correction, with all major product lines and geographies down. Strategic actions include manufacturing footprint reduction, inventory management, and new product launches, while guidance points to continued margin pressure and cautious recovery.

  • Net sales declined 6.2% sequentially, with gross margin and EPS slightly above guidance due to a legal settlement. Industrial and automotive markets, especially in Europe, were weak, while aerospace/defense and AI data center segments showed strength. Inventory and underutilization charges remain elevated.

  • Net sales declined 6.4% sequentially amid ongoing inventory correction and weak industrial and automotive demand, but cash generation and capital returns remain strong. Guidance for the September quarter anticipates further revenue softness, with continued focus on shareholder returns and new product launches.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020

Fiscal Year 2019

Fiscal Year 2018

Fiscal Year 2017

Powered by